Exposure to lead may be linked to cognitive problems decades later, according to three studies presented at the Alzheimer’s ...

Patients who used combinations of cardiovascular therapies experienced slower cognitive decline and fewer neuropathologies ...

Julia A. Haller, MD, ophthalmologist-in-chief at Wills Eye Hospital, has been named CEO, succeeding Joseph P. Bilson, ...

There was a lot of excitement when Tepezza became the first drug approved for the treatment of thyroid eye disease in January ...

Lyme disease is a complex condition with a long history of misdiagnosis, and Lyme arthritis, a late manifestation of the ...

Nicotine ingestions among young children declined 2015, but nicotine pouch ingestions more than 700% 2020, according to a ...

A 64-year-old woman presented to an outside provider with 5 days of left eye “burning, itching, redness and blurry vision” ...

A high dose of centanafadine was shown to be safe and effective at lowering ADHD symptoms for adolescents, according to ...

A multi-ancestry polygenic risk score could help health care professionals predict a person’s risk for developing obesity ...

Latanoprostene bunod 0.024% significantly reduced IOP across patient groups and appeared well regarded among physicians and ...

Commonly used sulfonylureas were associated with an up to 13% increase in risk for major adverse CV events vs.

One drop of Miebo had no significant impact on presurgical corneal measurements taken within 60 minutes of instillation, ...